CompletedNot Applicable

Assessing the Impact of COVID-19 on HMPV Incidence and Severity Among Adults

Turkey (Türkiye)2,197 participantsStarted 2023-12-15

Plain-language summary

Human metapneumovirus (HMPV) is primarily recognized as a childhood pathogen, but its impact on adults remains largely underestimated. This study investigates the prevalence, clinical characteristics, and post-COVID-19 trends of HMPV infection among adults in Istanbul, Turkey.

Who can participate

Age range18 Years – 100 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adults \>18 years * Patients with acute respiratory tract infection symptoms * Patients who underwent multiplex PCR testing for respiratory viruses Exclusion Criteria: * Patients for whom no respiratory viral panel test was conducted

What they're measuring

Prevalence of HMPV infection in adults pre- and post-COVID-19 pandemic

Timeframe: Between 2016-2020 (pre-COVID) and 2021-2023 (post-COVID)

Trial details

NCT IDNCT06309212

SponsorAcibadem University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-12-30

View on ClinicalTrials.gov More The Prevalance of HMPV After COVID-19 Pandemic trials